Olympus offers a lineup of self-expanding metal stents to help achieve luminal patency in a variety of clinical applications. With a hook-and-cross construction, the HANAROSTENT™ provides a balance of radial and axial force, allowing for the flexibility to conform to a patient’s anatomy and precisely target their stricture.

HANAROSTENT™ Esophagus (CCC) is a fully covered stent loaded on an over-the-wire deployment device

HANAROSTENT™ Esophagus (NCN) is a partially covered stent loaded on an over-the-wire deployment device

HANAROSTENT™ Esophagus Asymmetric (CCC) is a fully covered stent with a shorter proximal dumbbell loaded on an over-the-wire deployment device

Delivery systems are compatible with a 0.035” or 0.038” guidewire.

Indications for Use
The HANAROSTENT™ Esophagus (CCC) and HANAROSTENT™ Esophagus (NCN) and HANAROSTENT™ Esophagus Asymmetric (CCC) are intended for maintaining esophageal luminal patency in esophageal strictures caused by intrinsic and/or extrinsic malignant tumors, and occlusion of concurrent esophageal fistulas.

Contraindications
This stent is contraindicated for:

• Strictures that do not allow passage of a guidewire
• Strictures that cannot be dilated enough to pass the delivery device.
• Chronically bleeding tumors, if bleeding is active at the time of placement.
• Patients for whom the endoscopic treatments are contraindicated.
• Multiple sites of obstruction
• Standard endoscopy contraindications
• Strictures caused by benign tumors
• Any use other than those mentioned in Indications for Use